Investor Presentaiton
FULL-YEAR 2022 GUIDANCE
Total company outlook
in billions, except per share amounts
Q4:21 Earnings Call
Feb 9, 2022
Total Revenues
Adjusted Operating Income
GAAP EPS
Adjusted EPS
Cash Flow from Operations
$304 to $309
4-6%
$16.7 to $17.1
(4)-(1)%
$7.04 to $7.24
18-22%
$8.10 to $8.30
(4)-(1)%
$12.0 to $13.0
2021 Investor Day¹
Dec 9, 2021
$304 to $309
5-6%
$16.7 to $17.1
1-3%
$7.04 to $7.24
27-30%
$8.10 to $8.30
1-4%
$12.5 to $13.0
Maintaining
guidance for
revenues, adjusted
operating income,
and adjusted EPS
Updating guidance
range for cash flow
from operations
Percentages represent year-over-year growth from reported 2021 results.
1. Percentages represent year-over-year growth from FY21 Guidance shared at Investor Day on December 9, 2021. GAAP EPS percentages
represent year-over-year growth from mid-point of FY21 GAAP EPS Guidance shared at Investor Day on December 9, 2021.
2. Calculated versus 2021 baseline of $7.92 excluding prior years development (net of profits returned to customers), net redized capital gains and
includes the annualized impact from increase to minimum wage.
8
©2022 CVS Health and/or one of its affiliates.
♥CVSHealth.View entire presentation